Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.

Source:http://linkedlifedata.com/resource/pubmed/id/19637944

Download in:

View as

General Info

PMID
19637944